Philip E. Thorpe
66Patents
32h-index
13Co-inventors
85Inventor score
Filing activity: Aug 27, 1987 → Feb 27, 2015
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6342219B1 | Antibody compositions for selectively inhibiting VEGF | Emerging Cross-Sectional Technologies | 354 | Expired |
| US6051230A | Compositions for targeting the vasculature of solid tumors | Emerging Cross-Sectional Technologies | 258 | Expired |
| US5855866A | Methods for treating the vasculature of solid tumors | Chemistry; Metallurgy | 256 | Expired |
| US5776427A | Methods for targeting the vasculature of solid tumors | Chemistry; Metallurgy | 215 | Expired |
| US6342221B1 | Antibody conjugate compositions for selectively inhibiting VEGF | Emerging Cross-Sectional Technologies | 178 | Expired |
| US5877289A | Tissue factor compositions and ligands for the specific coagulation of vasculature | Chemistry; Metallurgy | 160 | Expired |
| US5660827A | Antibodies that bind to endoglin | Chemistry; Metallurgy | 130 | Expired |
| US6004555A | Methods for the specific coagulation of vasculature | Chemistry; Metallurgy | 118 | Expired |
| US4880935A | Heterobifunctional linking agents derived from N-succinimido-dithio-alpha methyl-methylene-benzoates | Chemistry; Metallurgy | 118 | Expired |
| US6524583B1 | Antibody methods for selectively inhibiting VEGF | Emerging Cross-Sectional Technologies | 116 | Expired |
| US6312694A | Cancer treatment methods using therapeutic conjugates that bind to aminophospholipids | Chemistry; Metallurgy | 109 | Expired |
| US6261535A | Diagnostic methods for targeting the vasculature of solid tumors | Emerging Cross-Sectional Technologies | 107 | Expired |
| US5863538A | Compositions for targeting the vasculature of solid tumors | Emerging Cross-Sectional Technologies | 107 | Expired |
| US6676941B2 | Antibody conjugate formulations for selectively inhibiting VEGF | Emerging Cross-Sectional Technologies | 93 | Expired |
| US6703020B1 | Antibody conjugate methods for selectively inhibiting VEGF | Chemistry; Metallurgy | 88 | Expired |
| US6093399A | Methods and compositions for the specific coagulation of vasculature | Chemistry; Metallurgy | 88 | Expired |
| US5965132A | Methods and compositions for targeting the vasculature of solid tumors | Emerging Cross-Sectional Technologies | 85 | Expired |
| US6036955A | Kits and methods for the specific coagulation of vasculature | Chemistry; Metallurgy | 80 | Expired |
| US6416758B1 | Antibody conjugate kits for selectively inhibiting VEGF | Emerging Cross-Sectional Technologies | 70 | Expired |
| US6156321A | Tissue factor methods and compositions for coagulation and tumor treatment | Emerging Cross-Sectional Technologies | 69 | Expired |
| US7125541B2 | Combined methods for tumor vasculature targeting and tumor treatment with radiotherapy | Emerging Cross-Sectional Technologies | 69 | Expired |
| US5474765A | Preparation and use of steroid-polyanionic polymer-based conjugates targeted to vascular endothelial cells | Human Necessities | 66 | Expired |
| US6004554A | Methods for targeting the vasculature of solid tumors | Chemistry; Metallurgy | 61 | Expired |
| US5762918A | Methods of using steroid-polyanionic polymer-based conjugated targeted to vascular endothelial cells | Human Necessities | 54 | Expired |
| US6406693B1 | Cancer treatment methods using antibodies to aminophospholipids | Chemistry; Metallurgy | 51 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.